Status:
COMPLETED
Usefulness of Cephalometry in the Second and Third Trimester of Pregnancy in the Diagnosis of Fetal Microretrognathia
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Pierre Robin Sequence
Eligibility:
All Genders
18-44 years
Brief Summary
Congenital retrognathia, with or without Pierre Robin Sequence (PRS), is a rare anomaly which can be associated with chromosomal abnormalities. Respiratory and feeding consequences can be present at b...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Pregnant patient (Aged \>18years old)
- with one or more fetuses suffering from a microretrognathia
- diagnosed prenatally
- integrated into a Pierre Robin Sequence
- Exclusion criteria:
- Uncvertain diagnosis
- Absence of 3D rendering volume
Exclusion
Key Trial Info
Start Date :
May 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04422067
Start Date
May 1 2019
End Date
September 30 2019
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295